GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Molecure SA (WAR:MOC) » Definitions » Notes Receivable

Molecure (WAR:MOC) Notes Receivable : zł0.00 Mil (As of Mar. 2025)


View and export this data going back to 2018. Start your Free Trial

What is Molecure Notes Receivable?

Molecure's Notes Receivable for the quarter that ended in Mar. 2025 was zł0.00 Mil.


Molecure Notes Receivable Historical Data

The historical data trend for Molecure's Notes Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Molecure Notes Receivable Chart

Molecure Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Notes Receivable
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Molecure Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Notes Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Molecure Notes Receivable Calculation

Notes Receivable is an unconditional promise to receive a definite sum of money at a future date(s) within one year of the balance sheet date or the normal operating cycle, whichever is longer.


Molecure Notes Receivable Related Terms

Thank you for viewing the detailed overview of Molecure's Notes Receivable provided by GuruFocus.com. Please click on the following links to see related term pages.


Molecure Business Description

Traded in Other Exchanges
N/A
Address
Zwirki i Wigury 101, Warsaw, POL, 02-089
Molecure SA is a biopharmaceutical company engaged in discovering, developing, and commercializing novel therapeutics for neoplastic and inflammatory diseases. The company is focused on discovering and developing molecules with potential to become first-in-class or best-in-class drugs worldwide to treat unmet medical needs.